首頁 > 市場調查報告書 > 醫療設備

血型鑑定市場規模、佔有率及成長分析（依產品類型、檢測類型、技術、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1901998

血型鑑定市場規模、佔有率及成長分析（依產品類型、檢測類型、技術、應用、最終用戶及地區分類）－2026-2033年產業預測

Blood Group Typing Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Test Type, By Technique, By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 196 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球血型檢測市場規模預計在 2024 年達到 20.6 億美元，從 2025 年的 22.5 億美元成長到 2033 年的 45.2 億美元，在預測期（2026-2033 年）內複合年成長率為 9.1%。

全球血型鑑定市場正經歷顯著成長，這主要得益於技術進步和醫療服務可近性的提高等多種因素。慢性病患者對輸血的需求日益成長，以及器官移植需求的不斷增加，都推動了市場擴張。基於PCR的方法、微陣列技術和大規模定序等創新技術顯著提高了血型鑑定的準確性和效率。此外，全球醫院、診所和診斷中心的快速成長也推動了對這些服務的需求。人工智慧和自動化技術在血型鑑定流程中的應用將進一步提高診斷速度和準確性。然而，高成本、基礎設施不足以及倫理方面的考慮等挑戰可能會阻礙血型鑑定在部分地區的市場滲透。整體而言，血型鑑定市場前景樂觀。

全球血型鑑定市場促進因素

全球血型鑑定市場蓬勃發展，這得益於各國政府為促進捐血和提高輸血安全而推出的各項措施。這些措施在提高公眾對血型鑑定服務的認知度和可及性方面發揮關鍵作用，對市場前景產生了積極影響。此外，公共衛生宣傳活動和對血型鑑定設備的財政支持也鼓勵醫療機構採用先進的血型鑑定技術。隨著這些措施的推進，血型鑑定技術的進步將擁有更有利的環境，最終將惠及整個醫療保健產業，並確保輸血安全。

全球血型鑑定市場限制因素

全球血型鑑定市場面臨嚴峻挑戰，主要原因是檢測結果不一致且難以保證結果的準確性。檢測方法、試劑品質和操作人員技術水準的差異是造成結果可靠性不足的原因。這些不一致會危及病人安全，並可能損害血型鑑定流程的可靠性。因此，這些挑戰可能會阻礙血型鑑定解決方案和服務的廣泛應用和整合，從而限制該領域的發展。解決這些問題對於確保血型鑑定實踐的有效性和可靠性至關重要。

全球血型鑑定市場趨勢

全球血型鑑定市場正經歷著從傳統血清學檢測方法向先進分子血型鑑定技術的重大轉變。這一趨勢的驅動力在於，人們對準確識別罕見或弱效血型抗原的需求日益成長，這在產前檢測和需要多次輸血的患者等複雜病例中至關重要。包括PCR和DNA定序在內的分子方法，在提高準確性的同時，最大限度地降低了同種免疫和輸血反應的風險。隨著醫療機構逐漸認知到這些創新技術的優勢，血型鑑定產業正迎來收入成長，並有望滿足病患和醫療專業人員不斷變化的需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Bio-Rad Laboratories, Inc.（United States）
Ortho Clinical Diagnostics（United States）
Quotient Limited（Switzerland）
Immucor, Inc.（United States）
Grifols SA（Spain）
Bio-Techne Corporation（United States）
DIAGAST（France）
Tulip Diagnostics（India）
AXO Science（France）
Beckman Coulter, Inc.（United States）
MTC Invitro Diagnostics（Germany）
BAG Diagnostics GmbH（Germany）
Rapid Labs Ltd.（United Kingdom）
NG Biotech（France）
Demeditec Diagnostics GmbH（Germany）
Sero AS（Norway）
Alcor Scientific Inc.（United States）
Tulip Group（India）
Medion Grifols Diagnostics AG（Switzerland）

結論與建議

簡介目錄

Product Code: SQMIG35D2309

Global Blood Group Typing Market size was valued at USD 2.06 Billion in 2024 and is poised to grow from USD 2.25 Billion in 2025 to USD 4.52 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global blood group typing market is witnessing significant growth due to various factors, including technological advancements and increasing healthcare access. The prevalence of chronic diseases that necessitate blood transfusions, along with a rising demand for organ transplants, is driving market expansion. Innovations such as PCR-based methods, microarray technologies, and massively parallel sequencing have markedly improved blood typing accuracy and efficiency. Additionally, the rapid proliferation of hospitals, clinics, and diagnostic centers globally enhances the demand for these services. The integration of AI and automation in blood typing processes further boosts diagnostic speed and precision. However, challenges such as high costs, inadequate infrastructure, and ethical considerations could hinder market penetration in various regions. Overall, the outlook for blood group typing remains robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Group Typing Market Segments Analysis

Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing growth driven by various government initiatives aimed at promoting blood donation and enhancing the safety of blood transfusions. These measures play a crucial role in raising awareness and improving access to blood typing services, thereby positively influencing market prospects. Additionally, public health campaigns and financial support for blood typing equipment are encouraging healthcare facilities to adopt cutting-edge technologies in blood typing. As these initiatives progress, they create a more conducive environment for advancements in blood group typing, ultimately benefiting the overall healthcare sector and ensuring the availability of safe transfusion practices.

Restraints in the Global Blood Group Typing Market

The Global Blood Group Typing market faces notable challenges due to inconsistencies in test results and difficulties in maintaining accurate outcomes. Variations in testing methods, the quality of reagents, and the skill levels of operators contribute to this lack of reliability. Such inconsistencies can pose risks to patient safety and undermine the credibility of blood typing processes. Consequently, these challenges may impede the wider acceptance and integration of blood group typing solutions and services, potentially limiting advancements in this sector. Addressing these issues is crucial for ensuring the efficacy and trustworthiness of blood group typing practices.

Market Trends of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing a significant shift towards the adoption of advanced molecular blood typing techniques, moving away from traditional serological methods. This trend is driven by the increasing demand for precision in identifying rare and weak blood group antigens, which is crucial for complex cases like prenatal testing and patients requiring multiple transfusions. Molecular methods, including PCR and DNA sequencing, enhance accuracy while simultaneously minimizing the risks of alloimmunization and transfusion reactions. As healthcare providers recognize the benefits of these innovative technologies, the blood group typing industry is poised for revenue growth, responding to the evolving needs of patients and medical professionals alike.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Startup Analysis
Raw Material Analysis

Global Blood Group Typing Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Consumables
- Antisera Reagents
- Anti-human Globulin Reagents
- Red Blood Cell Reagents
- Blood Bank Saline
Instruments
Services & Software

Global Blood Group Typing Market Size by Test Type & CAGR (2026-2033)

Market Overview
ABO Blood Tests & Rh Typing
Antibody Screening
HLA Typing
Cross-matching Tests
Antigen Typing

Global Blood Group Typing Market Size by Technique & CAGR (2026-2033)

Market Overview
Assay-based Techniques
PCR-based and Microarray Techniques
Massively Parallel Sequencing
Other Techniques

Global Blood Group Typing Market Size by Technology & CAGR (2026-2033)

Market Overview
Molecular Typing
Serological Typing
Microarray-based Typing
Next-generation Sequencing

Global Blood Group Typing Market Size by Application & CAGR (2026-2033)

Market Overview
Blood transfusions
Organ transplants
Diagnostic testing

Global Blood Group Typing Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Blood Banks
Clinical Laboratories
Other End Users

Global Blood Group Typing Market Size & CAGR (2026-2033)

North America (Product & Service, Test Type, Technique, Technology, Application, End User)
- US
- Canada
Europe (Product & Service, Test Type, Technique, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Test Type, Technique, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Test Type, Technique, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Test Type, Technique, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quotient Limited (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DIAGAST (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tulip Diagnostics (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AXO Science (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MTC Invitro Diagnostics (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BAG Diagnostics GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Labs Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NG Biotech (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Demeditec Diagnostics GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sero AS (Norway)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcor Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tulip Group (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medion Grifols Diagnostics AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments